{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:58:49Z","timestamp":1776423529917,"version":"3.51.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00078","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:13:33Z","timestamp":1550186013000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma"],"prefix":"10.3389","volume":"9","author":[{"given":"Jian-Guo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Han","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheleh","family":"Roudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur Respir J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/jclinpath-2013-201609","article-title":"Challenges and controversies in the diagnosis of malignant mesothelioma: part 2. malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA","volume":"66","author":"Henderson","year":"2013","journal-title":"J Clin Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/2211536605666160128151018","article-title":"Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma","volume":"5","author":"Truini","year":"2016","journal-title":"Microrna"},{"key":"B6","doi-asserted-by":"publisher","first-page":"9645940","DOI":"10.1155\/2017\/9645940","article-title":"MicroRNA expression in malignant pleural mesothelioma and asbestosis: a pilot study","volume":"2017","author":"Mozzoni","year":"2017","journal-title":"Dis Markers"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","article-title":"BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study","volume":"11","author":"Righi","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/bjc.2013.815","article-title":"Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma","volume":"110","author":"Ghanim","year":"2014","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/bjc.2015.9","article-title":"Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study","volume":"112","author":"Ghanim","year":"2015","journal-title":"Br J Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1038\/bjc.2014.117","article-title":"CD74: a new prognostic factor for patients with malignant pleural mesothelioma","volume":"110","author":"Otterstrom","year":"2014","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.3892\/or.2015.3771","article-title":"Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma","volume":"33","author":"Hirata","year":"2015","journal-title":"Oncol Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.lungcan.2014.06.018","article-title":"The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma","volume":"85","author":"Giroux Leprieur","year":"2014","journal-title":"Lung Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-9966-32-7","article-title":"SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma","volume":"32","author":"Zhang","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.omtn.2017.07.001","article-title":"MicroRNA-31 Regulates chemosensitivity in malignant pleural mesothelioma","volume":"8","author":"Moody","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"68627","DOI":"10.18632\/oncotarget.19800","article-title":"Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma","volume":"8","author":"Truini","year":"2017","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"De Santi","year":"2017","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/1471-2164-11-532","article-title":"Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma","volume":"11","author":"Lafferty-Whyte","year":"2010","journal-title":"BMC Genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J Clin Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","article-title":"Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling","volume":"166","author":"Gordon","year":"2005","journal-title":"Am J Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinform."},{"key":"B23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/biostatistics\/kxr031","article-title":"Normalization, testing, and false discovery rate estimation for RNA-sequencing data","volume":"13","author":"Li","year":"2012","journal-title":"Biostatistics (Oxford, England)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucl Acids Res."},{"key":"B25","unstructured":"TerryTL\n            TherneauM\n          Survival: Contains the Core Survival Analysis Routines, Including Definition of Surv objects, Kaplan-Meier and Aalen-Johansen (multi-state) Curves, Cox Models, and Parametric Accelerated Failure Time Models, R Package Version 2.42-4.2018"},{"key":"B26","unstructured":"P.S.-Patrick HeagertyCJ\n          Time-Dependent ROC Curve Estimation From Censored Survival Data, R Package Version 1.0.32018"},{"key":"B27","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for Evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"B32","unstructured":"Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma49637\n            GordonGJ\n            JensenRV\n            HsiaoLL\n            GullansSR\n            BlumenstockJE\n            RamaswamyS\n          12208747Cancer Res622002"},{"key":"B33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/jnci\/95.8.598","article-title":"Using gene expression ratios to predict outcome among patients with mesothelioma","volume":"95","author":"Gordon","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1158\/1078-0432.CCR-04-2181","article-title":"Validation of genomics-based prognostic tests in malignant pleural mesothelioma","volume":"11","author":"Gordon","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/jnci\/djp061","article-title":"Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma","volume":"101","author":"Gordon","year":"2009","journal-title":"J Natl Cancer Inst."},{"key":"B36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1158\/1078-0432.CCR-10-0806","article-title":"Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma","volume":"17","author":"De Rienzo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/JTO.0b013e3182a59f45","article-title":"Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia","volume":"8","author":"Ali","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"676731","DOI":"10.1155\/2012\/676731","article-title":"Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins","volume":"2012","author":"Bendas","year":"2012","journal-title":"Int J Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3647","volume":"14","author":"van Roy","year":"2014","journal-title":"Nat Rev Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T23:13:49Z","timestamp":1550186029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":39,"alternative-id":["10.3389\/fonc.2019.00078"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00078","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"article-number":"78"}}